Weiss Multi-Strategy Advisers’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-77,714
| Closed | -$13.4M | – | 839 |
|
|
2021
Q3 | $13.4M | Buy |
77,714
+39,671
| +104% | +$5.19M | 0.29% | 114 |
|
|
2021
Q2 | $4.77M | Sell |
38,043
-32
| -0.1% | -$4.04K | 0.11% | 271 |
|
|
2021
Q1 | $5.16M | Sell |
38,075
-2,309
| -6% | -$298K | 0.11% | 250 |
|
|
2020
Q4 | $5.17M | Sell |
40,384
-3,001
| -7% | -$352K | 0.1% | 257 |
|
|
2020
Q3 | $4.88M | Buy |
43,385
+3,385
| +8% | +$337K | 0.13% | 228 |
|
|
2020
Q2 | $3.81M | Buy |
40,000
+2,776
| +7% | +$268K | 0.11% | 244 |
|
|
2020
Q1 | $3.35M | Buy |
37,224
+20,224
| +119% | +$1.57M | 0.13% | 207 |
|
|
2019
Q4 | $901K | Buy |
17,000
+11,500
| +209% | +$524K | 0.01% | 498 |
|
|
2019
Q3 | $217K | Buy |
5,500
+500
| +10% | +$21.7K | ﹤0.01% | 542 |
|
|
2019
Q2 | $205K | Hold |
5,000
| – | – | 0.01% | 468 |
|
|
2019
Q1 | $233K | Buy |
+5,000
| New | +$220K | 0.01% | 473 |
|
|
2017
Q2 | – | Sell |
-20,000
| Closed | -$529K | – | 689 |
|
|
2017
Q1 | $529K | Buy |
20,000
+5,000
| +33% | +$132K | 0.02% | 443 |
|
|
2016
Q4 | $383K | Sell |
15,000
-578
| -4% | -$18.3K | 0.02% | 347 |
|
|
2016
Q3 | $564K | Sell |
15,578
-460
| -3% | -$15.2K | 0.03% | 333 |
|
|
2016
Q2 | $545K | Sell |
16,038
-11,462
| -42% | -$373K | 0.04% | 318 |
|
|
2016
Q1 | $726K | Buy |
27,500
+5,000
| +22% | +$145K | 0.03% | 360 |
|
|
2015
Q4 | $1.1M | Sell |
22,500
-2,500
| -10% | -$90K | 0.08% | 228 |
|
|
2015
Q3 | $623K | Sell |
25,000
-1,000
| -4% | -$30.1K | 0.03% | 305 |
|
|
2015
Q2 | $823K | Buy |
26,000
+6,500
| +33% | +$210K | 0.03% | 333 |
|
|
2015
Q1 | $742K | Buy |
+19,500
| New | +$775K | 0.03% | 342 |
|
Weiss Multi-Strategy Advisers's XLRN Position: Q4 2021 in Review
Weiss Multi-Strategy Advisers sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 77,714 shares — an estimated $13.4M sold.
Weiss Multi-Strategy Advisers first reported a position in XLRN in Q1 2015 and held it in 20 quarters. The position peaked at $13.4M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Weiss Multi-Strategy Advisers reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Weiss Multi-Strategy Advisers sold 77,714 Acceleron Pharma shares in Q4 2021, an estimated $13.4M.
- Weiss Multi-Strategy Advisers first reported a position in Acceleron Pharma in Q1 2015 and held it in 20 quarters.
- Weiss Multi-Strategy Advisers's Acceleron Pharma position peaked at $13.4M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.